Christian Thomas Farrar, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Protons | 10 | 2023 | 1116 | 1.340 |
Why?
|
| Magnetic Resonance Imaging | 39 | 2024 | 36426 | 1.190 |
Why?
|
| Oncolytic Virotherapy | 3 | 2021 | 516 | 0.960 |
Why?
|
| Genes, Reporter | 3 | 2023 | 1529 | 0.950 |
Why?
|
| Gadolinium | 4 | 2017 | 960 | 0.560 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 5 | 2016 | 664 | 0.510 |
Why?
|
| Liver Cirrhosis, Experimental | 1 | 2015 | 29 | 0.500 |
Why?
|
| RNA Probes | 2 | 2014 | 111 | 0.480 |
Why?
|
| Polysaccharides, Bacterial | 1 | 2017 | 578 | 0.480 |
Why?
|
| Liver Cirrhosis | 3 | 2020 | 1935 | 0.430 |
Why?
|
| Phantoms, Imaging | 8 | 2024 | 2526 | 0.420 |
Why?
|
| Aptamers, Nucleotide | 1 | 2014 | 165 | 0.410 |
Why?
|
| Brain Neoplasms | 7 | 2022 | 9031 | 0.400 |
Why?
|
| Fibrosis | 2 | 2020 | 2049 | 0.380 |
Why?
|
| Contrast Media | 10 | 2023 | 5311 | 0.370 |
Why?
|
| Molecular Imaging | 5 | 2020 | 815 | 0.350 |
Why?
|
| Lysine | 1 | 2015 | 993 | 0.350 |
Why?
|
| Image Interpretation, Computer-Assisted | 3 | 2019 | 3357 | 0.340 |
Why?
|
| Neovascularization, Pathologic | 5 | 2016 | 2645 | 0.340 |
Why?
|
| Magnetic Resonance Spectroscopy | 8 | 2022 | 3769 | 0.340 |
Why?
|
| Plaque, Amyloid | 1 | 2014 | 760 | 0.330 |
Why?
|
| Manganese | 5 | 2016 | 395 | 0.310 |
Why?
|
| Energy Transfer | 1 | 2008 | 108 | 0.310 |
Why?
|
| Hydrogen-Ion Concentration | 4 | 2019 | 2496 | 0.310 |
Why?
|
| Microscopy, Fluorescence, Multiphoton | 1 | 2010 | 267 | 0.300 |
Why?
|
| Sirolimus | 1 | 2015 | 1533 | 0.300 |
Why?
|
| Electron Spin Resonance Spectroscopy | 6 | 2000 | 162 | 0.290 |
Why?
|
| Arginine | 3 | 2022 | 934 | 0.280 |
Why?
|
| Spin Labels | 2 | 2008 | 337 | 0.280 |
Why?
|
| Glioma | 3 | 2011 | 3455 | 0.280 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2023 | 9000 | 0.260 |
Why?
|
| Disease Models, Animal | 12 | 2020 | 18252 | 0.260 |
Why?
|
| Magnetics | 2 | 2008 | 599 | 0.250 |
Why?
|
| Mice | 26 | 2023 | 81525 | 0.250 |
Why?
|
| Animals | 34 | 2023 | 168459 | 0.240 |
Why?
|
| Magnetite Nanoparticles | 2 | 2017 | 318 | 0.230 |
Why?
|
| Quinazolines | 5 | 2016 | 1371 | 0.230 |
Why?
|
| Image Enhancement | 4 | 2019 | 2885 | 0.220 |
Why?
|
| Liver | 2 | 2020 | 7529 | 0.210 |
Why?
|
| Blood Vessels | 4 | 2014 | 1113 | 0.210 |
Why?
|
| Rats | 6 | 2020 | 23742 | 0.200 |
Why?
|
| Water | 4 | 2013 | 1411 | 0.200 |
Why?
|
| Ferrosoferric Oxide | 2 | 2017 | 348 | 0.200 |
Why?
|
| Pancreas | 2 | 2020 | 1691 | 0.190 |
Why?
|
| Algorithms | 8 | 2024 | 14031 | 0.190 |
Why?
|
| Ice | 1 | 2022 | 102 | 0.190 |
Why?
|
| Tissue Distribution | 4 | 2017 | 2265 | 0.190 |
Why?
|
| Threonine | 4 | 1998 | 271 | 0.190 |
Why?
|
| p120 GTPase Activating Protein | 1 | 2000 | 36 | 0.180 |
Why?
|
| Elasticity Imaging Techniques | 2 | 2016 | 392 | 0.180 |
Why?
|
| Oncogene Protein p21(ras) | 1 | 2000 | 68 | 0.180 |
Why?
|
| Trityl Compounds | 1 | 2000 | 13 | 0.180 |
Why?
|
| Arteriosclerosis | 1 | 2005 | 1055 | 0.180 |
Why?
|
| Rats, Wistar | 3 | 2020 | 1848 | 0.180 |
Why?
|
| Protein Engineering | 1 | 2023 | 549 | 0.160 |
Why?
|
| Programming Languages | 1 | 2019 | 128 | 0.160 |
Why?
|
| Body Temperature | 1 | 2022 | 781 | 0.160 |
Why?
|
| Reproducibility of Results | 8 | 2022 | 20098 | 0.160 |
Why?
|
| Carbon Tetrachloride | 1 | 2017 | 72 | 0.150 |
Why?
|
| Glioblastoma | 4 | 2016 | 3482 | 0.150 |
Why?
|
| Blood-Brain Barrier | 3 | 2013 | 1027 | 0.150 |
Why?
|
| Computer Simulation | 7 | 2023 | 6240 | 0.150 |
Why?
|
| Herpesvirus 1, Human | 1 | 2023 | 753 | 0.140 |
Why?
|
| Biosensing Techniques | 1 | 2023 | 650 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 1998 | 1745 | 0.140 |
Why?
|
| Nanoparticles | 3 | 2017 | 1959 | 0.140 |
Why?
|
| Half-Life | 1 | 2017 | 651 | 0.140 |
Why?
|
| Amines | 1 | 2018 | 281 | 0.140 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2016 | 149 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2011 | 5671 | 0.120 |
Why?
|
| Chelating Agents | 1 | 2016 | 387 | 0.120 |
Why?
|
| Antibodies, Neoplasm | 1 | 2016 | 281 | 0.120 |
Why?
|
| Blood Volume | 2 | 2013 | 547 | 0.120 |
Why?
|
| Brain | 7 | 2022 | 27112 | 0.120 |
Why?
|
| Ligation | 1 | 2015 | 448 | 0.120 |
Why?
|
| Bile Ducts | 1 | 2015 | 282 | 0.110 |
Why?
|
| Rats, Inbred F344 | 1 | 2015 | 826 | 0.110 |
Why?
|
| Base Pairing | 1 | 2014 | 140 | 0.110 |
Why?
|
| Gadolinium DTPA | 2 | 2017 | 823 | 0.110 |
Why?
|
| Peroxidase | 1 | 2016 | 609 | 0.110 |
Why?
|
| Mice, Nude | 4 | 2018 | 3615 | 0.110 |
Why?
|
| Alzheimer Disease | 2 | 2014 | 8599 | 0.110 |
Why?
|
| Liposomes | 1 | 2017 | 784 | 0.110 |
Why?
|
| Quantum Dots | 1 | 2014 | 167 | 0.110 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2017 | 678 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2023 | 992 | 0.110 |
Why?
|
| Neuropilin-1 | 1 | 2013 | 90 | 0.100 |
Why?
|
| Monte Carlo Method | 1 | 2018 | 1258 | 0.100 |
Why?
|
| Microwaves | 2 | 2011 | 185 | 0.100 |
Why?
|
| Mannitol | 1 | 2012 | 180 | 0.100 |
Why?
|
| Obesity, Morbid | 1 | 2023 | 1277 | 0.100 |
Why?
|
| Pregnancy Proteins | 1 | 2013 | 222 | 0.100 |
Why?
|
| Cysteine | 1 | 2016 | 891 | 0.100 |
Why?
|
| Escherichia coli | 2 | 2023 | 4217 | 0.100 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14666 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2020 | 4278 | 0.090 |
Why?
|
| Simplexvirus | 1 | 2015 | 803 | 0.090 |
Why?
|
| Peptides | 3 | 2024 | 4358 | 0.090 |
Why?
|
| Neoplasms, Experimental | 1 | 2016 | 1229 | 0.090 |
Why?
|
| Immunoblotting | 1 | 2014 | 1646 | 0.090 |
Why?
|
| Islets of Langerhans | 1 | 2017 | 1341 | 0.090 |
Why?
|
| Diabetes Mellitus, Experimental | 1 | 2017 | 1119 | 0.090 |
Why?
|
| Cell Line, Tumor | 7 | 2020 | 16981 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 2 | 2020 | 5368 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2017 | 2192 | 0.090 |
Why?
|
| Doxorubicin | 1 | 2017 | 2224 | 0.090 |
Why?
|
| Breast Neoplasms | 4 | 2023 | 21012 | 0.090 |
Why?
|
| Fibrin | 1 | 2012 | 507 | 0.080 |
Why?
|
| Microscopy, Video | 1 | 2010 | 241 | 0.080 |
Why?
|
| Meningeal Neoplasms | 1 | 2018 | 1248 | 0.080 |
Why?
|
| Angiopoietin-2 | 1 | 2010 | 172 | 0.080 |
Why?
|
| Linear Models | 1 | 2019 | 5871 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2011 | 563 | 0.080 |
Why?
|
| Diffusion | 1 | 2011 | 814 | 0.080 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2020 | 1727 | 0.080 |
Why?
|
| Neoadjuvant Therapy | 1 | 2020 | 2827 | 0.080 |
Why?
|
| Amino Acid Sequence | 1 | 2020 | 13446 | 0.080 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 1 | 2011 | 509 | 0.080 |
Why?
|
| Humans | 32 | 2024 | 761504 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 5 | 2020 | 3602 | 0.080 |
Why?
|
| Carbon Dioxide | 1 | 2012 | 1147 | 0.080 |
Why?
|
| Cerebellar Neoplasms | 1 | 2013 | 586 | 0.070 |
Why?
|
| Gene Amplification | 1 | 2012 | 1089 | 0.070 |
Why?
|
| Macrophages | 2 | 2016 | 5769 | 0.070 |
Why?
|
| Medulloblastoma | 1 | 2013 | 678 | 0.070 |
Why?
|
| Drug Delivery Systems | 2 | 2017 | 2226 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2010 | 546 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2011 | 773 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2022 | 2578 | 0.070 |
Why?
|
| ROC Curve | 1 | 2015 | 3579 | 0.070 |
Why?
|
| Stavudine | 1 | 2007 | 85 | 0.070 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 22169 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2013 | 1432 | 0.070 |
Why?
|
| Fluorescent Dyes | 1 | 2014 | 1903 | 0.070 |
Why?
|
| Blotting, Western | 1 | 2014 | 5035 | 0.070 |
Why?
|
| Vibration | 1 | 2008 | 328 | 0.070 |
Why?
|
| Mitochondria, Muscle | 1 | 2007 | 172 | 0.060 |
Why?
|
| Radio Waves | 2 | 2005 | 251 | 0.060 |
Why?
|
| Cerebellum | 1 | 2013 | 1501 | 0.060 |
Why?
|
| Apoptosis | 1 | 2021 | 9486 | 0.060 |
Why?
|
| Software | 1 | 2019 | 4434 | 0.060 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 9539 | 0.060 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 2529 | 0.060 |
Why?
|
| Indoles | 2 | 2011 | 1833 | 0.060 |
Why?
|
| Brain Edema | 1 | 2009 | 604 | 0.060 |
Why?
|
| Crystallography, X-Ray | 2 | 2000 | 1990 | 0.060 |
Why?
|
| Molecular Structure | 2 | 2016 | 1880 | 0.060 |
Why?
|
| Microscopy | 1 | 2009 | 903 | 0.060 |
Why?
|
| Oligonucleotides | 1 | 2007 | 582 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2020 | 9280 | 0.060 |
Why?
|
| Guanylyl Imidodiphosphate | 3 | 1998 | 37 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2016 | 3617 | 0.060 |
Why?
|
| Pulsatile Flow | 1 | 2005 | 321 | 0.060 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2007 | 621 | 0.060 |
Why?
|
| Glycine | 2 | 2011 | 663 | 0.050 |
Why?
|
| Molecular Probes | 2 | 2020 | 309 | 0.050 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2009 | 952 | 0.050 |
Why?
|
| Protamines | 1 | 2023 | 112 | 0.050 |
Why?
|
| Binding Sites | 4 | 2000 | 6055 | 0.050 |
Why?
|
| Base Sequence | 1 | 2014 | 12441 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2023 | 286 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2003 | 458 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2010 | 6132 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2015 | 18965 | 0.050 |
Why?
|
| Receptor, erbB-2 | 1 | 2012 | 2557 | 0.050 |
Why?
|
| Male | 12 | 2023 | 360804 | 0.050 |
Why?
|
| Antineoplastic Agents | 3 | 2016 | 13639 | 0.050 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2007 | 740 | 0.050 |
Why?
|
| Visual Cortex | 1 | 2009 | 1107 | 0.050 |
Why?
|
| Molecular Sequence Data | 1 | 2014 | 17635 | 0.050 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2811 | 0.050 |
Why?
|
| Creatine | 1 | 2023 | 427 | 0.050 |
Why?
|
| Reference Values | 1 | 2008 | 4920 | 0.050 |
Why?
|
| Gene Silencing | 1 | 2007 | 1509 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 2000 | 154 | 0.040 |
Why?
|
| Chalcones | 1 | 2020 | 30 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 2000 | 507 | 0.040 |
Why?
|
| Solutions | 1 | 2000 | 412 | 0.040 |
Why?
|
| Fourier Analysis | 1 | 2000 | 441 | 0.040 |
Why?
|
| Propionates | 1 | 2020 | 183 | 0.040 |
Why?
|
| Heterocyclic Compounds | 1 | 2020 | 246 | 0.040 |
Why?
|
| Thermodynamics | 1 | 2000 | 595 | 0.040 |
Why?
|
| Ribonucleotide Reductases | 1 | 1999 | 76 | 0.040 |
Why?
|
| Artifacts | 1 | 2007 | 1911 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2012 | 10445 | 0.040 |
Why?
|
| Guanosine Triphosphate | 2 | 1996 | 316 | 0.040 |
Why?
|
| Amides | 1 | 2021 | 449 | 0.040 |
Why?
|
| Leucovorin | 1 | 2020 | 643 | 0.040 |
Why?
|
| Macromolecular Substances | 1 | 2000 | 1434 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 3530 | 0.040 |
Why?
|
| Heart Failure | 1 | 2022 | 11669 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2013 | 2016 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3429 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1997 | 168 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2000 | 1693 | 0.040 |
Why?
|
| Diethylnitrosamine | 1 | 2016 | 45 | 0.040 |
Why?
|
| Amino Acids | 1 | 2023 | 1718 | 0.040 |
Why?
|
| Oleic Acid | 1 | 2017 | 92 | 0.030 |
Why?
|
| Carbocyanines | 1 | 2017 | 175 | 0.030 |
Why?
|
| Organometallic Compounds | 1 | 2020 | 647 | 0.030 |
Why?
|
| Equipment Design | 1 | 2005 | 3510 | 0.030 |
Why?
|
| Female | 10 | 2023 | 392644 | 0.030 |
Why?
|
| Analysis of Variance | 2 | 2016 | 6228 | 0.030 |
Why?
|
| Amino Acid Substitution | 1 | 2000 | 1738 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2022 | 1989 | 0.030 |
Why?
|
| Pancreatectomy | 1 | 2020 | 811 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2022 | 1440 | 0.030 |
Why?
|
| Glycerol | 2 | 2011 | 274 | 0.030 |
Why?
|
| Temperature | 1 | 2022 | 2226 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2020 | 1641 | 0.030 |
Why?
|
| Heart | 1 | 2008 | 4404 | 0.030 |
Why?
|
| Glucose | 1 | 2007 | 4346 | 0.030 |
Why?
|
| Virus Replication | 1 | 2023 | 2435 | 0.030 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 11076 | 0.030 |
Why?
|
| Fatty Acids | 1 | 2022 | 1808 | 0.030 |
Why?
|
| Transplantation, Heterologous | 2 | 2013 | 2385 | 0.030 |
Why?
|
| Albumins | 1 | 2017 | 575 | 0.030 |
Why?
|
| Survival Analysis | 2 | 2020 | 10090 | 0.030 |
Why?
|
| Nitric Oxide | 1 | 2003 | 2135 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2012 | 6346 | 0.030 |
Why?
|
| Angiogenesis Inhibitors | 2 | 2014 | 2047 | 0.030 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2016 | 718 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2007 | 3049 | 0.030 |
Why?
|
| Silicon Dioxide | 1 | 2014 | 216 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2007 | 7594 | 0.030 |
Why?
|
| Particle Size | 1 | 2017 | 1648 | 0.030 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 2014 | 278 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 2395 | 0.030 |
Why?
|
| Trypan Blue | 1 | 2011 | 22 | 0.020 |
Why?
|
| Swine | 1 | 2022 | 5915 | 0.020 |
Why?
|
| Fluorescence | 1 | 2014 | 756 | 0.020 |
Why?
|
| Collagen | 1 | 2020 | 2638 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2007 | 4948 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 1626 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 4575 | 0.020 |
Why?
|
| Paracrine Communication | 1 | 2013 | 277 | 0.020 |
Why?
|
| Mucin-1 | 1 | 2016 | 540 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2022 | 2882 | 0.020 |
Why?
|
| Luminescent Measurements | 1 | 2012 | 342 | 0.020 |
Why?
|
| Stroke | 1 | 2013 | 9757 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2012 | 629 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2000 | 5439 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 2231 | 0.020 |
Why?
|
| Alkaloids | 1 | 2011 | 192 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2023 | 3879 | 0.020 |
Why?
|
| Adipose Tissue | 1 | 2022 | 3312 | 0.020 |
Why?
|
| Proline | 1 | 2011 | 457 | 0.020 |
Why?
|
| Optics and Photonics | 1 | 2011 | 306 | 0.020 |
Why?
|
| Electromagnetic Fields | 1 | 2011 | 296 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2020 | 6814 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2013 | 23445 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 1994 | 951 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 558 | 0.020 |
Why?
|
| Myocardium | 1 | 2022 | 4726 | 0.020 |
Why?
|
| Protein Conformation | 1 | 1996 | 3968 | 0.020 |
Why?
|
| Microcirculation | 1 | 2013 | 1273 | 0.020 |
Why?
|
| Necrosis | 1 | 2012 | 1611 | 0.020 |
Why?
|
| Proteins | 1 | 2023 | 6032 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2017 | 6216 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2018 | 4915 | 0.020 |
Why?
|
| Photons | 1 | 2011 | 589 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2012 | 2065 | 0.020 |
Why?
|
| Myocardial Infarction | 1 | 2008 | 11460 | 0.020 |
Why?
|
| Cell Death | 1 | 2012 | 1678 | 0.020 |
Why?
|
| Genes, fos | 1 | 2007 | 176 | 0.020 |
Why?
|
| Colorectal Neoplasms | 1 | 2007 | 6935 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2023 | 54425 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2012 | 1893 | 0.020 |
Why?
|
| Glucose Clamp Technique | 1 | 2007 | 263 | 0.020 |
Why?
|
| Phosphocreatine | 1 | 2007 | 261 | 0.020 |
Why?
|
| Quinolines | 1 | 2011 | 764 | 0.020 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2020 | 11742 | 0.020 |
Why?
|
| Apolipoproteins E | 1 | 2011 | 1444 | 0.020 |
Why?
|
| Phosphorus | 1 | 2007 | 336 | 0.020 |
Why?
|
| Ferric Compounds | 1 | 2007 | 378 | 0.020 |
Why?
|
| Transfection | 1 | 2012 | 5774 | 0.010 |
Why?
|
| Carotid Artery, Internal | 1 | 2007 | 445 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2007 | 1991 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2012 | 2200 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 12059 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1900 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 2 | 1998 | 517 | 0.010 |
Why?
|
| Metal Nanoparticles | 1 | 2007 | 399 | 0.010 |
Why?
|
| Diet | 1 | 2020 | 8075 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2012 | 5247 | 0.010 |
Why?
|
| DNA, Mitochondrial | 1 | 2007 | 865 | 0.010 |
Why?
|
| Nanotechnology | 1 | 2007 | 714 | 0.010 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2012 | 2790 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12947 | 0.010 |
Why?
|
| Protein Binding | 2 | 2007 | 9351 | 0.010 |
Why?
|
| Cell Survival | 1 | 2010 | 5791 | 0.010 |
Why?
|
| Allyl Compounds | 1 | 1999 | 22 | 0.010 |
Why?
|
| Kinetics | 2 | 1998 | 6374 | 0.010 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 860 | 0.010 |
Why?
|
| Middle Aged | 3 | 2023 | 220895 | 0.010 |
Why?
|
| Benzene Derivatives | 1 | 1999 | 53 | 0.010 |
Why?
|
| Prognosis | 1 | 2020 | 29625 | 0.010 |
Why?
|
| Bacteriophages | 1 | 2003 | 378 | 0.010 |
Why?
|
| Polystyrenes | 1 | 1999 | 104 | 0.010 |
Why?
|
| Methylglucosides | 1 | 1998 | 35 | 0.010 |
Why?
|
| Free Radicals | 1 | 1999 | 238 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2016 | 15842 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
| Deuterium | 1 | 1998 | 106 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 8002 | 0.010 |
Why?
|
| Transducers | 1 | 1999 | 244 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2016 | 64680 | 0.010 |
Why?
|
| Freezing | 1 | 1998 | 311 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2013 | 14414 | 0.010 |
Why?
|
| Cryoprotective Agents | 1 | 1998 | 128 | 0.010 |
Why?
|
| Body Composition | 1 | 2007 | 2426 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1999 | 453 | 0.010 |
Why?
|
| Oxygen Isotopes | 1 | 1996 | 43 | 0.010 |
Why?
|
| Models, Biological | 1 | 2013 | 9469 | 0.010 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 1996 | 353 | 0.010 |
Why?
|
| Anisotropy | 1 | 1999 | 1283 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2012 | 9177 | 0.010 |
Why?
|
| Time Factors | 2 | 2012 | 39967 | 0.010 |
Why?
|
| Tyrosine | 1 | 1999 | 1440 | 0.010 |
Why?
|
| Guanosine Diphosphate | 1 | 1994 | 80 | 0.010 |
Why?
|
| Asparagine | 1 | 1994 | 119 | 0.010 |
Why?
|
| Insulin Resistance | 1 | 2007 | 3963 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 1994 | 576 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2020 | 80636 | 0.010 |
Why?
|
| Phosphates | 1 | 1994 | 770 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 169289 | 0.000 |
Why?
|
| Ligands | 1 | 1994 | 3272 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1994 | 6534 | 0.000 |
Why?
|
| Adult | 1 | 2007 | 221177 | 0.000 |
Why?
|